Abstract
Transcatheter Pulmonary Valve Implantation (TPVI) has emerged as an attractive therapeutic option for the treatment of right ventricular outflow tract dysfunction. By 2015, more than 7000 transcatheter pulmonary valve implantation have been performed. Two valves are currently used for TPVI. The Melody Valve (MeV) (Medtronic Inc., Minneapolis, Minnesota), which can be expanded to 22 mm diameter. The Edward Sapien Valve (ESV) (Edwards Lifesciences LLC, Irvine, California), which can be expanded to 26 mm diameter. This chapter summarizes the concept, its evolution in clinical practice, current applications, and the devices in current use. Early and mid-term outcomes are presented as well as projected long term results and future developments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.
Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–97.
Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–72.
Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. Clinical trial. J Am Coll Cardiol. 2009;54:1722–9.
McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507–16.
Eicken A, Ewert P, Hager A, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260–5.
Fraisse A, Aldebert P, Malekzadeh-Milani S, Thambo JB, Piéchaud JF, Aucoururier P, Chatelier G, Bonnet D, Iserin L, Bonello B, Assaidi A, Kammache I, Boudjemline Y. Melody transcatheter pulmonary valve implantation: results from a french registry. Arch Cardiovasc Dis. 2014;107:607–14.
Butera G, Milanesi O, Spadoni I, et al. Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology. Catheter Cardiovasc Interv. 2013;81:310–6.
Kenny D, Hijazi ZM, Kar S. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58:2248–56.
Haas NA, Moysich A, Neudorf U, et al. Percutaneous implantation of the Edwards SAPIEN(™) pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol. 2013;102:119–28.
Rubio-Alvarez V, Limon R, Soni J. [Intracardiac valvulotomy by means of a catheter]. Arch Inst Cardiol Mex. 1953;23:183–92.
Kan JS, White Jr RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982;307:540–2.
Zeevi B, Keane JF, Perry SB, et al. Balloon dilation of postoperative right ventricular outflow obstructions. J Am Coll Cardiol. 1989;14:401–8.
Almagor Y, Prevosti LG, Bartorelli AL, et al. Balloon expandable stent implantation in stenotic right heart valved conduits. J Am Coll Cardiol. 1990;16:1310–4.
Ovaert C, Caldarone CA, McCrindle BW, et al. Endovascular stent implantation for the management of postoperative right ventricular outflow tract obstruction: clinical efficacy. J Thorac Cardiovasc Surg. 1999;118:886–93.
Sugiyama H, Williams W, Benson LN. Implantation of endovascular stents for the obstructive right ventricular outflow tract. Heart. 2005;91:1058–63.
McElhinney DB, Hennesen JT. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci. 2013;1291:77–85.
Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67:659–62.
Cheatham SL, Holzer RJ, Chisolm JL, Cheatham JP. The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter – it works. Catheter Cardiovasc Interv. 2013;82:816–23.
Boone RH, Webb JG, Horlick E, et al. Transcatheter pulmonary valve implantation using the Edwards SAPIENTM transcatheter heart valve. Catheter Cardiovasc Interv. 2010;75:286–94.
Feltes TF, Bacha E, Beekman RH, et al. Indications for cardiac catheterization & and intervention in pediatric cardiac disease. Circulation. 2011;123:2607–52.
Gillespie MJ, Rome JJ, Levi DS. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862–70.
Meadows JJ, Moore PM, Berman DP. Use and performance of the melody transcatheter pulmonary valve in native and postsurgical, nonconduit right ventricular outflow tracts. Circ Cardiovasc Interv. 2014;7:374–80.
Malekzadeh-Milani S, Ladouceur M, Cohen S, Iserin L, Boudjemline Y. Results of transcatheter pulmonary valvulation in native or patched right ventricular outflow tracts. Arch Cardiovasc Dis. 2014;107:592–8.
Berman DP, McElhinney DB, Vincent JA, Hillenbrand WE, Zahn EM. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits. Circ Cardiovasc Interv. 2014;7:142–8.
Schievano S, Coats L, Migliavacca F, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson. 2007;9:687–95.
Boudjemline Y, Agnoletti G, Bonnet D, et al. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract: an experimental study. J Am Coll Cordial. 2004;43:1082–7.
Boudjemline Y, Brugada G, Van-Aerschot I. Outcomes and safety of transcatheter pulmonary valve replacement in patients with large patched right ventricular outflow tracts. Arch Cardiovasc Dis. 2012;105:404–13.
Fraisse A, Assaidi A, Mauri L, et al. Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: Incidence, diagnosis and outcome. Catheter Cardiovasc Interv. 2014;83:E260–8.
Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6:535–42.
Daskalopoulos DA, Edwards WD, Driscoll DJ, Danielson GK, Puga FJ. Coronary artery compression with fatal myocardial ischemia. J Thorac Cardiovasc Surg. 1983;85:546–51.
Lurz P, Puranik R, Nordmeyer J, et al. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J. 2009;30:2266–74.
Schievano S, Taylor AM, Capelli C, et al. First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. EuroIntervention. 2010;5:745–50.
Cao QL, Kenny D, Zhou D, Pan W, Ge J, Hijazi ZM. Early experience with a novel self-expanding percutaneous stent-valve in the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2014;84:1131–7.
Demkow M, Rużyłło W, Biernacka EK, et al. Percutaneous Edwards SAPIEN(™) valve implantation for significant pulmonary regurgitation after previous surgical repair with a right ventricular outflow patch. Catheter Cardiovasc Interv. 2014;83:474–81.
Nordmeyer J, Khambadkone S, Coats L, et al. Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation. 2007;115:1392–7.
McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve failure, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US melody valve trial. Circ Cardiovasc Interv. 2011;4:602–14.
Nordmeyer J, Lurz P, Khambadkone S, et al. Prestenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart. 2011;97:118–23.
Balzer DT. Percutaneous pulmonary valve implantation: fixing the problems and pushing the envelope. Curr Opin Pediatr. 2012;24:565–8.
Nordmeyer J, Coats L, Lurz P, et al. Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J. 2008;29:810–5.
Atamanyuk I, Raja SG, Kostolny M. Bartonella Henselae endocarditis of percutaneously implanted pulmonary valve: a case report. J Heart Valve Dis. 2011;20:94–7.
Patel M, Iserin L, Bonnet D, Boudjemline Y. Atypical malignant late infective endocarditis of Melody valve. J Thorac Cardiovasc Surg. 2012;143:e32–5.
Alsoufi B, Al-joufan M, Al-Omrani A, Bulbul Z. Obstruction of a percutaneous pulmonary valve by an aspergillus mycotic thrombus mimicking massive pulmonary embolus. Ann Thorac Surg. 2012;94:e5–6.
Bhat D, Forbes TJ, Aggarwal S. A case of life-threatening Staphylococcus aureus endocarditis involving percutaneous transcatheter prosthetic pulmonary valve. Congenit Heart Dis. 2013;8:E161–4.
Buber J, Bergersen L, Lock JE. Bloodstream infections occurring in patients with percutaneously implanted bio-prosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv. 2013;6:301–10.
McElhinney D, Benson L, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the melody valve: combined results of 3 prospective North American and European Studies. Circ Cardiovasc Interv. 2013;6:292–300.
Villafañe J, Baker GH, Austin EH, Miller S, Peng L, Beekman R. Melody® pulmonary valve bacterial endocarditis: experience in four pediatric patients and a review of the literature. Catheter Cardiovasc Interv. 2014;84:212–8.
Tiete AR, Sachweh S, Roemer U, Kozlik-Fredmann R, Reuchart B, Daebritz SH. Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution. Ann Thorac Surg. 2004;77:2151–6.
Shebani SO, McGuirk S, Baghai M, et al. Right ventricular outflow tract reconstruction using Contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg. 2006;29:397–405.
Baslaim G. Bovine valved xenograft (Contegra) conduit in the extracardiac Fontan procedure: the preliminary experience. J Card Surg. 2008;23:146–9.
Bajraktari G, Olloni R, Daullxhiu I, Ademaj F, Vela Z, Pajaziti M. MRSA endocarditis of bovine Contegra valved conduit: a case report. Cases J. 2009;2:57.
Stefanidis C, Benahmed-Mostafa A, Sanoussi A, Quiriny M, Demanet H, Theunissen C, et al. Edocarditis of bovine jugular vein conduit due to Q fever. Ann Thorac Surg. 2011;91:1990–2.
Prior N, Alphonso N, Arnold P, et al. Bovine jugular vein valved conduit: up to 10 years follow-up. J Thorac Cardiovasc Surg. 2011;141:983–7.
Breymann T, Blanz U, Wojtalik M, et al. European Contegra Multicenter Study: 7-year results after valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg. 2009;57:257–69.
Albanesi F, Sekarski N, Lambrou D, Von Segesser LK, Berdajs DA. Incidence and risk factors for Contegra graft infection following right ventricular outflow tract reconstruction: long-term results. Eur J Cardiothorac Surg. 2014;45:1070–4.
Cheung G, Vejlstrup N, Ihlemann N, et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. Int J Cardiol. 2013;169:425–9.
Lee C, Park CS, Lee CH. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. Cardiovasc Surg. 2011;142:351–8.
Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993;329:593–9.
Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–7.
Plymen CM, Bolger AP, Lurz P, et al. Electrical remodeling following percutaneous pulmonary valve implantation. Am J Cardiol. 2011;107:309–14.
Therrien J, Siu S, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489–94.
Lurz P, Giardini A, TayloR AM, et al. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am J Cardiol. 2010;105:721–6.
Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440–6.
Ortega M, Triedman JK, Geva T, et al. Relation of left ventricular dyssynchrony measured by cardiac magnetic resonance tissue tracking in repaired tetralogy of fallot to ventricular tachycardia and death. Am J Cardiol. 2011;107:1535–40.
Harrild DM, Marcus E, Hasan B, et al. Impact of transcatheter pulmonary valve replacement on biventricular strain and synchrony assessed by cardiac magnetic resonance feature tracking. Circ Cardiovasc Interv. 2013;6:680–7.
Eyskens B, Reybrouck T, Bogaert J, et al. Homograft insertion for pulmonary regurgitation after repair of tetralogy of Fallot improves cardiorespiratory exercise performance. Am J Cardiol. 2000;85:221–5.
Müller J, Engelhardt A, Fratz S, Eicken A, Ewert P, Hager A. Improved exercise performance and quality of life after percutaneous pulmonary valve implantation. Int J Cardiol. 2014;173:388–92.
Batra AS, McElhinney DB, Wang W, et al. Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial. Am Heart J. 2012;163:280–7.
Lutter G, Metzner A, Jahnke T, Bombien R, Boldt J, Iino K, Cremer J, Stock UA. Percutaneous tissue-engineered pulmonary valved stent implantation. Ann Thorac Surg. 2010;89:259–63.
Boldt J, Lutter G, Pohanke J, Fischer G, Schoettler J, Cremer J, Metzner A. Percutaneous tissue-engineered pulmonary valved stent implantation: comparison of bone marrow-derived CD133+-cells and cells obtained from carotid artery. Tissue Eng Part C Methods. 2013;19:363–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Trivedi, K.R., Oswal, N., Fraisse, A. (2016). Transcatheter Pulmonary Valvulation. In: Lacour-Gayet, F., Bove, E., Hraška, V., Morell, V., Spray, T. (eds) Surgery of Conotruncal Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-319-23057-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-23057-3_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23056-6
Online ISBN: 978-3-319-23057-3
eBook Packages: MedicineMedicine (R0)